The aim is to evaluate the effectiveness of adjuvant therapy in treating patients with colon and rectal cancer.
Randomized trial design
Assessment of treatment outcomes based on different therapy regimens
Analysis of biomarkers related to treatment response
Adjuvant therapy shows significant improvement in disease-free survival rates.
Notable enhancement in overall survival compared to standard treatment.
Specific biomarkers correlated with better treatment outcomes.
Abstract
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue